Related Experiment Videos
Intensive induction chemotherapy in elderly patients. The BGMT Group
British Journal of Haematology
|September 1, 1992
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Current practices and challenges in the management of nonmetastatic pancreatic adenocarcinoma: results of an EORTC survey.
ESMO gastrointestinal oncology·2026
Therapy for squamous-cell carcinoma of the anus in HIV-positive patients.
ESMO gastrointestinal oncology·2026
Local and symptomatic control evaluation in palliative radiotherapy for rectal adenocarcinoma in frail, elderly, or metastatic patients: a multicentric retrospective study.
Clinical and translational radiation oncology·2026
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.
British journal of haematology·2024
[Informed consent in radiotherapy care].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.
British journal of haematology·2026
CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.
British journal of haematology·2026
The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.
British journal of haematology·2026
First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.
Expert review of pharmacoeconomics & outcomes research·2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.
International journal of urology : official journal of the Japanese Urological Association·2026
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.
Neuro-oncology advances·2026